Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131959) titled 'Application of Propranolol Combined with Neoadjuvant Endocrine Therapy in Prostate Cancer: An Open-label Safety Exploratory Study' on Sept. 8.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: The Third Affiliated Hospital Sun Yat-sen University
Condition:
High-risk localized or locally advanced prostate adenocarcinoma
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2027-01-01
Target Sample Size: Propranolol combined with neoadjuvant endocrine therapy group:12;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.ht...